Analyst Ratings For NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT)
Today, Seaport Global Securities initiated coverage on NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT) with a Buy with a price target of $32.00.
Some recent analyst ratings include
- 4/13/2018-Seaport Global Securities initiated coverage with a Buy rating.
- 3/8/2018-B. Riley initiated coverage with a Buy rating.
- 12/20/2016-Janney Montgomery Scott initiated coverage with a Sell rating.
Recent Insider Trading Activity For NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT)
NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT) has insider ownership of 19.20% and institutional ownership of 77.22%.
- On 4/6/2018 Robert S Fishman, Insider, sold 8,000 with an average share price of $16.22 per share and the total transaction amounting to $129,760.00.
- On 3/7/2018 Renee D Gala, Director, bought 10,000 with an average share price of $15.51 per share and the total transaction amounting to $155,100.00.
- On 3/7/2018 Robert S Fishman, Insider, sold 8,000 with an average share price of $15.67 per share and the total transaction amounting to $125,360.00.
- On 2/7/2018 Robert S Fishman, Insider, sold 8,000 with an average share price of $16.60 per share and the total transaction amounting to $132,800.00.
- On 1/8/2018 Robert S Fishman, Insider, sold 8,000 with an average share price of $18.67 per share and the total transaction amounting to $149,360.00.
- On 12/8/2017 Robert S Fishman, Insider, sold 8,000 with an average share price of $16.72 per share and the total transaction amounting to $133,760.00.
- On 11/13/2017 G Leonard Baker Jr, Director, sold 30,000 with an average share price of $17.59 per share and the total transaction amounting to $527,700.00.
Recent Trading Activity for NASDAQ:CORT – Corcept Therapeutics (NASDAQ:CORT)
Shares of NASDAQ:CORT – Corcept Therapeutics closed the previous trading session at 17.13 up +0.37 2.21% with 17.209999084472656 shares trading hands.